Optimizing the Treatment of Advanced Prostate Cancer: Expert Review of the Latest Data and Guideline Recommendations

In these downloadable slidesets Celestia S. Higano, MD, FACP, Andrew Armstrong, MD, ScM, FACP, Alan H. Bryce, MD, and Tanya B. Dorff, MD, review recent developments and NCCN guideline recommendations in the optimal care of patients with advanced prostate cancer. To view an On-demand webcast of this program available from the National Comprehensive Cancer Network website, please click here.
Supported by educational grants from
Astellas Pharma Global Development, Inc. Medical Affairs, Americas
Bayer HealthCare Pharmaceuticals Inc.
Dendreon Pharmaceuticals, Inc.
Medivation, Inc.
Tokai Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?